IIPR: A Most Peculiar Bloom

The matter of Innovative Industrial Properties – IIPR, as the tickers insist on abbreviating it – is, shall we say, curious. This week, the shares have ascended a full 16%, a movement not unlike a startled pigeon. The cause? Earnings, announced with the solemnity of a state funeral, revealed a decline – a full 13% in both revenue and those curiously named “funds from operations.” Yet, the market, that fickle beast, responded with a cheer. It is as if a physician announced a patient’s wasting sickness, and the onlookers applauded the robustness of the diagnosis.

The decline, you understand, is merely… temporary. A consequence of disputes – litigations, they call them – over defaults. These are, naturally, being resolved, though one suspects at a pace dictated by the whims of clerks and the proliferation of paperwork. It is a drop, therefore, not of substance, but of illusion. The stock, having languished for five years – a veritable eternity in the feverish world of finance – required but the slightest encouragement to stir. One might compare it to a slumbering bear, roused not by a roar, but by a particularly insistent fly.

The dividend yield, now a staggering 13.9%, hangs in the air like a particularly ripe plum, tempting yet precarious. Maintaining such a payout requires, naturally, a rebound in those aforementioned “funds.” Alan Gold, Chairman of the Board and a man who appears to have stepped directly from a Dostoevsky novel, expresses optimism. He speaks of “releasing activity” and the resolution of litigations, as if these were benevolent spirits guiding the company towards prosperity. One pictures him, surrounded by stacks of legal documents, murmuring incantations to appease the gods of finance.

We’re seeing strong releasing activity which is driving revenue … and we have the resolutions of some of these major lease litigations. And with those resolutions, and the activity, the leasing activity we’re seeing, we continuously feel positive about where we are with regards to our dividend.

But the truly peculiar aspect of this tale is the $150 million commitment to IQHQ, an “upstart life sciences REIT.” Mr. Gold, it seems, spent six years as executive chair of this venture, a fact that feels less like diversification and more like a benevolent patriarch guiding a younger sibling. IIP is to receive a yield of 13.5% on a revolving credit facility and 15% on preferred stock. It is a tidy arrangement, one that suggests a network of connections as intricate and baffling as a spider’s web. The founding of Alexandria Real Estate Equities by Mr. Gold only deepens the mystery. One begins to suspect a hidden hand orchestrating events from the shadows.

The Enterprise Value to FFO ratio of 9, and a net debt to EBITDA ratio of 1.4 times, are figures that, while unremarkable in themselves, take on a strange significance in this context. It is as if the numbers are whispering secrets, hinting at opportunities obscured by layers of bureaucracy and financial maneuvering. IIP, buoyed by the winds of cannabis and life sciences, presents itself as an intriguing, if somewhat unsettling, proposition. One approaches it not with the cold logic of an analyst, but with the cautious curiosity of a traveler venturing into a forgotten corner of the world.

2026-02-28 00:22

Read More